# | Title | Journal | Year | Citations |
---|
1 | Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection | American Journal of Gastroenterology | 2002 | 1,878 |
2 | Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study | Lancet, The | 2015 | 625 |
3 | Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation | Lancet, The | 1997 | 487 |
4 | Hepatitis C–associated hepatocellular carcinoma | Hepatology | 1990 | 236 |
5 | The role of laparoscopy in the diagnosis of cirrhosis | Gastrointestinal Endoscopy | 1996 | 200 |
6 | Controlled-Release, Pegylation, Liposomal Formulations: New Mechanisms in the Delivery of Injectable Drugs | Annals of Pharmacotherapy | 2000 | 158 |
7 | Atypical clinical manifestations of hepatitis A | Vaccine | 1992 | 148 |
8 | Hepatitis C and alcohol | Hepatology | 1997 | 148 |
9 | Statins in the Treatment of Dyslipidemia in the Presence of Elevated Liver Aminotransferase Levels: A Therapeutic Dilemma | Mayo Clinic Proceedings | 2010 | 130 |
10 | Risk Factors for New-Onset Diabetes Mellitus in Adult Liver Transplant Recipients, an Analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing Database | Transplantation | 2010 | 126 |
11 | Large cystic lesions of the liver in adults: a 15-year experience in a tertiary center | Journal of the American College of Surgeons | 2001 | 121 |
12 | Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation | Liver Transplantation | 2004 | 114 |
13 | A Retrospective Review of Liver Transplant Patients Treated with Sirolimus from a Single Center: An Analysis of Sirolimus-Related Complications | Transplantation | 2004 | 111 |
14 | A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis | Journal of Hepatology | 2020 | 111 |
15 | The Role of Donor Bone Marrow Infusions in Withdrawal of Immunosuppression in Adult Liver Allotransplantation | American Journal of Transplantation | 2005 | 110 |
16 | Biliary Complications Following Liver Transplantation | Digestive Diseases and Sciences | 2010 | 106 |
17 | Hepatic dysfunction accompanying acute cocaine intoxication | Journal of Hepatology | 1991 | 100 |
18 | Acetaminophen safety and hepatotoxicity – where do we go from here? | Expert Opinion on Drug Safety | 2007 | 95 |
19 | A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update | Clinical Gastroenterology and Hepatology | 2015 | 90 |
20 | Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non‐alcoholic fatty liver disease | Liver International | 2009 | 87 |
21 | Clinical trial: the efficacy and safety of oral PF‐03491390, a pancaspase inhibitor – a randomized placebo‐controlled study in patients with chronic hepatitis C | Alimentary Pharmacology and Therapeutics | 2010 | 87 |
22 | Extrahepatic manifestations of chronic viral hepatitis | Current Gastroenterology Reports | 2001 | 86 |
23 | Chronic Liver Disease in the Hispanic Population of the United States | Clinical Gastroenterology and Hepatology | 2011 | 85 |
24 | Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis | Hepatology | 1992 | 84 |
25 | Randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantation | Liver Transplantation | 2013 | 83 |
26 | Hepatitis C Virus in Alcoholic Patients with and without Clinically Apparent Liver Disease | Alcoholism: Clinical and Experimental Research | 1995 | 77 |
27 | A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA | Journal of Hepatology | 2021 | 77 |
28 | Transient hepatopulmonary syndrome in a patient with acute hepatitis A | Journal of Viral Hepatitis | 2001 | 76 |
29 | Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results | Hepatology | 2009 | 75 |
30 | Approach to a Liver Mass | Seminars in Liver Disease | 1993 | 72 |
31 | Elbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4–5 chronic kidney disease: clinical, virological, and health-related quality-of-life outcomes from a phase 3, multicentre, randomised, double-blind, placebo-controlled trial | The Lancet Gastroenterology and Hepatology | 2017 | 71 |
32 | Importance of HCV genotype 1 subtypes for drug resistance and response to therapy | Journal of Viral Hepatitis | 2014 | 65 |
33 | Interferon-induced chronic active hepatitis? | Gastroenterology | 1991 | 62 |
34 | LIVER DISEASE IN THE ELDERLY | Gastroenterology Clinics of North America | 2001 | 60 |
35 | A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis | Hepatology Communications | 2019 | 58 |
36 | Outcome of COVID‐19 in Patients With Autoimmune Hepatitis: An International Multicenter Study | Hepatology | 2021 | 56 |
37 | Hispanics With Primary Biliary Cirrhosis Are More Likely to Have Features of Autoimmune Hepatitis and Reduced Response to Ursodeoxycholic Acid Than Non-Hispanics | Clinical Gastroenterology and Hepatology | 2014 | 55 |
38 | Novel and emerging therapies for cholestatic liver diseases | Liver International | 2018 | 53 |
39 | Utilization of deceased donors during a pandemic: argument against using SARS-CoV-2–positive donors | American Journal of Transplantation | 2020 | 53 |
40 | Hepatitis C: Diagnostic Assays | Seminars in Liver Disease | 1995 | 50 |
41 | Malignancy in Crohn's disease | American Journal of Gastroenterology | 1996 | 50 |
42 | Liver cancer: A leading cause of cancer death in the United States and the role of the 1945–1965 birth cohort by ethnicity | JHEP Reports | 2019 | 48 |
43 | Absence of anti-LKM-1 antibody in hepatitis C viral infection in the United States of America | Journal of Viral Hepatitis | 1995 | 46 |
44 | The Impact of Campath 1H Induction in Adult Liver Allotransplantation | Transplantation Proceedings | 2005 | 45 |
45 | Endoscopic and histological features of mycophenolate mofetil colitis in patients after solid organ transplantation | Annals of Gastroenterology | 2015 | 44 |
46 | Combined Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Outcome After Liver Transplantation | Digestive Diseases and Sciences | 2010 | 42 |
47 | Histopathological changes after microwave coagulation therapy for patients with hepatocellular carcinoma: review of 15 explanted livers | American Journal of Gastroenterology | 2003 | 40 |
48 | Primary Biliary Cirrhosis is More Severe in Overweight Patients | Journal of Clinical Gastroenterology | 2013 | 38 |
49 | The Impact of Race on Survival After Hepatocellular Carcinoma in a Diverse American Population | Digestive Diseases and Sciences | 2018 | 37 |
50 | Antimitochondrial Antibody–Negative Primary Biliary Cirrhosis | Gastroenterology Clinics of North America | 2008 | 35 |